We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

SUV Max as Predictor of Outcome in Cervical Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01262144
First Posted: December 17, 2010
Last Update Posted: December 17, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
November 23, 2010
December 17, 2010
December 17, 2010
August 2010
Not Provided
Administration of adjuvant therapy [ Time Frame: immediately following surgery ]
Same as current
No Changes Posted
Overall survival [ Time Frame: surgery - present day ]
Same as current
Not Provided
Not Provided
 
SUV Max as Predictor of Outcome in Cervical Cancer
A Study to Evaluate the Value of SUV-Max in PET-FDG in Predicting Outcome of Surgery Vis a Vis Need for Radiotherapy

Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging. However, some patients received surgery after staging and subsequently require radio/chemotherapy due to findings on operation.

This study will attempt to find a correlation between SUV-Max on PET-CT and subsequent outcomes i.e. need for adjuvant therapy.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Females age 18-80, diagnosed with cervical cancer
Cervical Cancer
Radiation: Radiotherapy
Radiotherapy for cervical cancer
Case group
Intervention: Radiation: Radiotherapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
Not Provided
Not Provided

Inclusion Criteria:

  • having stating PET-CT stored on site
  • treated with surgery

Exclusion Criteria:

  • not eligible for surgery based on PET-CT, clinical stage
Sexes Eligible for Study: Female
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01262144
421CTIL
No
Not Provided
Not Provided
Dr. Amit Amnon, director, gynecologic oncology unit, Rambam Health Care Campus
Rambam Health Care Campus
Not Provided
Principal Investigator: Amnon Amit, MD Rambam Health Care Campus
Rambam Health Care Campus
November 2010